Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $210.9K in total
- 4
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +4 vs. previous quarter
- 43
- 13F valueReported value at the end of Q2 2026
- $28.5M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding VRCA, Q2 2026
No superinvestor reported holding VRCA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Verrica Pharmaceuticals Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 (view filing)5:00 PM ET | Aug 17 | 1 day | Zawitz DavidChief Operating Officer | PPurchase | +6.00K | $4.98 | +$29.9K | +28.6%27.0K after | |
| Aug 18, 2026 (view filing)5:00 PM ET | Aug 14-17 | 4 days | Rieger JaysonCEO and President | PPurchase | +25.0K | $5.03 | +$125.8K | +13.7%207.6K after | 2 lots |
| Aug 18, 2026 (view filing)5:00 PM ET | Aug 17-18 | 1 day | Rosenberg Noah L.CMO | PPurchase | +6.23K | $4.91 | +$30.6K | +264.3%8.59K after | 2 lots |
| Aug 18, 2026 (view filing)5:00 PM ET | Aug 18 | Same day | Kirby John J.Interim CFO | PPurchase | +5.00K | $4.93 | +$24.6K | +26.4%24.0K after | |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Zawitz DavidChief Operating Officer | PPurchase | +10.0K | $4.24 | +$42.4K | +90.9%21.0K after | |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Zawitz DavidChief Operating Officer | PPurchase | +2.50K | – | – | –2.50K after | Derivative |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Rieger JaysonCEO and President | PPurchase | +94.3K | $4.24 | +$399.9K | +106.8%182.6K after | |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Rieger JaysonCEO and President | PPurchase | +23.6K | – | – | –23.6K after | Derivative |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Rosenberg Noah L.CMO | PPurchase | +2.36K | $4.24 | +$9.99K | New position2.36K after | |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Rosenberg Noah L.CMO | PPurchase | +589 | – | – | –589 after | Derivative |
Top 10 13F holders, Q2 2026
The largest institutional positions in Verrica Pharmaceuticals Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caligan Partners LP | 923,910 | $5.65M | 0.27% | 00.0% | Unchanged |
| Cannell Capital LLC | 783,923 | $4.80M | 3.35% | +98,800+14.4% | Added |
| Affinity Asset Advisors, LLC | 707,338 | $4.33M | 0.21% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 471,559 | $2.89M | 1.77% | 00.0% | Unchanged |
| Armistice Capital, LLC | 426,304 | $2.61M | 0.07% | −91,877−17.7% | Reduced |
| Boothbay Fund Management, LLC | 280,734 | $1.72M | 0.03% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 279,310 | $1.71M | 0.00% | +90,552+48.0% | Added |
| Mariner, LLC | 207,230 | $1.27M | 0.00% | +182,686+744.3% | Added |
| Geode Capital Management, LLC | 138,160 | $845.7K | 0.00% | −757−0.5% | Reduced |
| BlackRock, Inc. | 74,344 | $455.0K | 0.00% | +35,791+92.8% | Added |
Holders of 5% or more of VRCA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Verrica Pharmaceuticals Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Caligan Partners LP | 13G | 9.99%15.9M shares | New | Feb 12, 20251 filing | Feb 12, 2025 | SEC |
| Armistice Capital, LLC | 13G/A | 9.99%9.24M shares | 0.00 ppfrom 9.99% | Feb 14, 20252 filings | May 15, 2025 | SEC |